Pages that link to "Q28276294"
Jump to navigation
Jump to search
The following pages link to Artemisinin Action and Resistance in Plasmodium falciparum (Q28276294):
Displaying 50 items.
- Recent advances in malaria genomics and epigenomics (Q28069435) (← links)
- Antibiotics in malaria therapy: which antibiotics except tetracyclines and macrolides may be used against malaria? (Q28076750) (← links)
- Plasmodium falciparum K13 Mutations Differentially Impact Ozonide Susceptibility and Parasite Fitness In Vitro (Q33555297) (← links)
- A Variant PfCRT Isoform Can Contribute to Plasmodium falciparum Resistance to the First-Line Partner Drug Piperaquine (Q33654512) (← links)
- The clinical impact of artemisinin resistance in Southeast Asia and the potential for future spread (Q33655603) (← links)
- Artemisinin resistance without pfkelch13 mutations in Plasmodium falciparum isolates from Cambodia (Q33668137) (← links)
- The Plasmodium PI(4)K inhibitor KDU691 selectively inhibits dihydroartemisinin-pretreated Plasmodium falciparum ring-stage parasites (Q33725824) (← links)
- H2O2 dynamics in the malaria parasite Plasmodium falciparum (Q36331838) (← links)
- High-resolution cryo-EM proteasome structures in drug development. (Q36392578) (← links)
- In vitro activity of anti-malarial ozonides against an artemisinin-resistant isolate (Q37607795) (← links)
- Malaria parasite clearance (Q37663369) (← links)
- Knockout of the peroxiredoxin 5 homologue PFAOP does not affect the artemisinin susceptibility of Plasmodium falciparum (Q38699220) (← links)
- Design, synthesis and antimalarial activity of novel bis{N-[(pyrrolo[1,2-a]quinoxalin-4-yl)benzyl]-3-aminopropyl}amine derivatives. (Q38719909) (← links)
- Targeting proteasomes in infectious organisms to combat disease (Q39103077) (← links)
- Protein Degradation Systems as Antimalarial Therapeutic Targets (Q39422863) (← links)
- Hexahydroquinolines are antimalarial candidates with potent blood-stage and transmission-blocking activity (Q39552647) (← links)
- Hydrogen peroxide dynamics in subcellular compartments of malaria parasites using genetically encoded redox probes. (Q40065680) (← links)
- Antimalarial drug resistance: linking Plasmodium falciparum parasite biology to the clinic (Q40106428) (← links)
- Enterocin AS-48 as Evidence for the Use of Bacteriocins as New Leishmanicidal Agents (Q41695546) (← links)
- Platinum(ii)-chloroquine complexes are antimalarial agents against blood and liver stages by impairing mitochondrial function (Q41911875) (← links)
- How to tackle antimalarial resistance? (Q42101487) (← links)
- malERA: An updated research agenda for basic science and enabling technologies in malaria elimination and eradication (Q47162062) (← links)
- Multi-omics Based Identification of Specific Biochemical Changes Associated With PfKelch13-Mutant Artemisinin-Resistant Plasmodium falciparum (Q47990882) (← links)
- Using in Vitro Evolution and Whole Genome Analysis To Discover Next Generation Targets for Antimalarial Drug Discovery. (Q49927350) (← links)
- Anti-plasmodial effect of plant extracts from Picrolemma huberi and Picramnia latifolia. (Q52609454) (← links)
- Profiling of the anti-malarial drug candidate SC83288 against artemisinins in Plasmodium falciparum. (Q52646479) (← links)
- Imidazolopiperazines Kill both Rings and Dormant Rings in Wild-Type and K13 Artemisinin-Resistant Plasmodium falciparum In Vitro. (Q52659761) (← links)
- Amodiaquine resistance in Plasmodium berghei is associated with PbCRT His95Pro mutation, loss of chloroquine, artemisinin and primaquine sensitivity, and high transcript levels of key transporters. (Q55286880) (← links)
- Malaria (Q56378965) (← links)
- The proteasome as a target to combat malaria: hits and misses (Q56380854) (← links)
- Antiparasitic activity of chicory (Cichorium intybus) and its natural bioactive compounds in livestock: a review (Q57612880) (← links)
- Identification and mechanistic understanding of dihydroorotate dehydrogenase point mutations in Plasmodium falciparum that confer in vitro resistance to the clinical candidate DSM265 (Q58092418) (← links)
- Artemisinin kills malaria parasites by damaging proteins and inhibiting the proteasome (Q58726136) (← links)
- Isoxazolopyrimidine-Based Inhibitors of Dihydroorotate Dehydrogenase with Antimalarial Activity (Q58776522) (← links)
- Screening for potential prophylactics targeting sporozoite motility through the skin (Q58781866) (← links)
- Manipulating Eryptosis of Human Red Blood Cells: A Novel Antimalarial Strategy? (Q60048463) (← links)
- Artemether and Praziquantel: Origin, Mode of Action, Impact, and Suggested Application for Effective Control of Human Schistosomiasis (Q60949181) (← links)
- Association of mutations in the Plasmodium falciparum Kelch13 gene (Pf3D7_1343700) with parasite clearance rates after artemisinin-based treatments-a WWARN individual patient data meta-analysis (Q61446764) (← links)
- The past, present and future of anti-malarial medicines (Q62983704) (← links)
- Resistance to Artemisinin Combination Therapies (ACTs): Do Not Forget the Partner Drug! (Q64232067) (← links)
- Plasmodium chaperonin TRiC/CCT identified as a target of the antihistamine clemastine using parallel chemoproteomic strategy (Q90008883) (← links)
- A systematic review on anti-malarial drug discovery and antiplasmodial potential of green synthesis mediated metal nanoparticles: overview, challenges and future perspectives (Q90463382) (← links)
- Profiles of Kelch mutations in Plasmodium falciparum across South Asia and their implications for tracking drug resistance (Q90672938) (← links)
- In Silico Investigation of the Decline in Clinical Efficacy of Artemisinin Combination Therapies Due to Increasing Artemisinin and Partner Drug Resistance (Q91700481) (← links)
- Comparative structural and evolutionary analyses predict functional sites in the artemisinin resistance malaria protein K13 (Q92134518) (← links)
- The genomic architecture of antimalarial drug resistance (Q92231044) (← links)
- Analysis of Global Research on Malaria and Plasmodium vivax (Q92493210) (← links)
- Protozoan persister-like cells and drug treatment failure (Q92833523) (← links)
- Kinetic Driver of Antibacterial Drugs against Plasmodium falciparum and Implications for Clinical Dosing (Q92881014) (← links)
- Gene silencing through RNAi and antisense Vivo-Morpholino increases the efficacy of pyrethroids on larvae of Anopheles stephensi (Q92962420) (← links)